Putao Cen

Putao Cen

Oncology
6400 Fannin St
Suite 2900
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer.

Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026

Comparative Effectiveness of Radiofrequency or Microwave Ablation and Chemotherapy for the Treatment of Large (>5 cm) Hepatocellular Carcinoma Tumors.

Comparative Effectiveness of Radiofrequency or Microwave Ablation and Chemotherapy for the Treatment of Large (>5 cm) Hepatocellular Carcinoma Tumors.

Journal: Cureus
Published: April 06, 2026

Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.

Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.

Journal: The Journal of international medical research
Published: March 26, 2026

Double Hit in Clear-Cell Renal Cell Carcinoma With Germline Pathogenic ATM Mutation and Somatic VHL Mutation.

Double Hit in Clear-Cell Renal Cell Carcinoma With Germline Pathogenic ATM Mutation and Somatic VHL Mutation.

Journal: Journal of investigative medicine high impact case reports
Published: October 06, 2024

Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract.

Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract.

Journal: Journal of investigative medicine high impact case reports
Published: May 28, 2024

Promising Response of Olaparib in Patient With Germline ATM-Mutated Metastatic Gastric Cancer.

Promising Response of Olaparib in Patient With Germline ATM-Mutated Metastatic Gastric Cancer.

Journal: Journal of investigative medicine high impact case reports
Published: March 20, 2024

Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation.

Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation.

Journal: Journal of investigative medicine high impact case reports
Published: February 12, 2024

EUS-guided radiofrequency ablation for pancreatic adenocarcinoma.

EUS-guided radiofrequency ablation for pancreatic adenocarcinoma.

Journal: Gastrointestinal endoscopy
Published: January 28, 2024

A novel case of EUS-guided targeted radiofrequency ablation of metastatic duodenal renal cell carcinoma.

A novel case of EUS-guided targeted radiofrequency ablation of metastatic duodenal renal cell carcinoma.

Journal: Endoscopic ultrasound
Published: November 24, 2022

Palliative Endoscopic Salvage of a Functionally Obstructed Gastrojejunostomy - Report of Technique.

Palliative Endoscopic Salvage of a Functionally Obstructed Gastrojejunostomy - Report of Technique.

Journal: CRSLS : MIS case reports from SLS
Published: August 26, 2022

Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer.

Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer.

Journal: Cancer immunology research
Published: May 09, 2022

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.

Journal: Scientific reports
Published: April 26, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026